By Justin Petrone

The California Institute of Regenerative Medicine last week awarded Fluidigm $1.9 million to further develop its stem cell culture chip.

The grant was one of 19 made by the state agency, which doled out $32 million in total to create tools and technologies that help move stem cell research into clinical trials.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.